Baht 0.5 million in Q1/2019. The interest expenses in Q1/2020 was Baht 1.8 million, or 38.03% decreased from Baht 3.0 million of Q1/2019. This was due to the decrease in short term loan requirement

) Q1/2020 Q1/2019 Increase/(decrease) % Revene Revenue from sales 99,844 51,495 48,349 93.89 Revenue from services 1,967 25,685 (23,718) (92.34) Cost of Sale (71,275) (41,034) 30,241 (73.70) Cost of

the condition of the decrease of income. In addition, the company is better aware during times of crisis. Cash flow in operations is important to business operations. The Company has negotiated with

1,898 (729) -38% Other non-current liabilities 9 9 0 0% Total shareholders’ equity 6,098 9,016 (2,918) -32% • Total assets decline of 31% mainly are results of decrease in other non-current of financial

increase was partially offset by a decrease in interest expenses from reducing loan amounts as well as allowance reversal from debt repayment from the securities business receivable and Innotech Asset

decrease in expenses of beauty business. 2. Financial Performance Summary – by business Revenues by business THB’000 Consolidated Q2/2020 Q2/2019 ∆% Distributor of medical devices and equipment 430,615

deteriorate from 36% to 32% of revenue. This was not only attributed to the decrease of SW revenue but also from the rising cost of SW patients. Number of insurers increased and consequently more visits of SW

Million Baht decreased when compared to June 30, 2019 of 177.35 Million Baht, mostly came from decline in current assets by decreased in equivalent to cash of 6.74 Million Baht, decrease in trade account

32.8% from energy favorable prices. Costs were controlled and the total expenses in quarter 3 reported at Baht 333.6 million, a decrease of 25.9% over the same period last year. As a result, the Company

investment plan to strengthen leading position causing network opex to increase 3.3%YoY and flat QoQ. However, this was offset by decrease in cost related to revenue, such as regulatory fee and prepaid